Research location
Modena
Emilia-Romagna, Italy
Advertisement
Research activity in Modena
Emilia-Romagna, ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 83 trials and 83 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Modena
83 linked trials · page 2 of 2A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) ParticipantsNCT01941940 · 2013-09-05 · 1 site observation
COMPLETED
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller MedicationNCT01868061 · 2013-07-31 · 1 site observation
COMPLETED
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of IllnessNCT01959659 · 2013-05-01 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentNCT01702571 · 2012-11-27 · 1 site observation
COMPLETED
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease TherapyNCT01677754 · 2012-10-24 · 1 site observation
COMPLETED
Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesNCT01618370 · 2012-07-22 · 1 site observation
COMPLETED
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple SclerosisNCT01457924 · 2011-11-01 · 1 site observation
COMPLETED
Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive SubjectsNCT01449929 · 2011-10-31 · 1 site observation
COMPLETED
Airflow Limitation in Cardiac Diseases in EuropeNCT01485159 · 2011-10-01 · 1 site observation
COMPLETED
An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)NCT01394276 · 2011-05-01 · 1 site observation
COMPLETED
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic LeukemiaNCT01313689 · 2011-04-14 · 1 site observation
COMPLETED
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)NCT01378962 · 2011-03-31 · 1 site observation
COMPLETED
Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast CancerNCT01234337 · 2011-02-21 · 1 site observation
COMPLETED
A Study of Gantenerumab in Participants With Prodromal Alzheimer's DiseaseNCT01224106 · 2010-11-30 · 1 site observation
COMPLETED
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive AdultsNCT01231516 · 2010-10-26 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)NCT01120184 · 2010-07-31 · 1 site observation
COMPLETED
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01017952 · 2009-09-25 · 1 site observation
COMPLETED
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-InhibitorNCT01557348 · 2009-06-01 · 1 site observation
COMPLETED
Effects of Oral L-Arginine on Chronic Hypertension in PregnancyNCT00571766 · 2007-11-01 · 1 site observation
COMPLETED
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
L-arginine Effects on Chronic Hypertension in PregnancyNCT00974714 · 2007-09-01 · 1 site observation
COMPLETED
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive SubjectsNCT00549198 · 2007-06-01 · 1 site observation
COMPLETED
Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast CancerNCT00422903 · 2007-04-01 · 1 site observation
COMPLETED
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)NCT00413205 · 2007-01-01 · 1 site observation
COMPLETED
Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast CancerNCT00429299 · 2006-08-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.NCT00451906 · 2006-08-01 · 1 site observation
COMPLETED
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerNCT00338247 · 2006-07-01 · 1 site observation
APPROVED_FOR_MARKETING
A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast CancerNCT01674062 · 2006-05-01 · 1 site observation
COMPLETED
A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast CancerNCT00333775 · 2006-03-01 · 1 site observation
COMPLETED
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksNCT00085943 · 2004-05-01 · 1 site observation
COMPLETED
Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)NCT02093026 · 2002-08-01 · 1 site observation
COMPLETED
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected SubjectsNCT00044577 · 2002-07-16 · 1 site observation
COMPLETED
A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 YearsNCT00040664 · 2002-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.